These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1372950

  • 1. Treatment of ventricular arrhythmias after CAST.
    Tonkin AM.
    Med J Aust; 1992 Apr 06; 156(7):488-92. PubMed ID: 1372950
    [Abstract] [Full Text] [Related]

  • 2. Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
    Anderson JL, Platia EV, Hallstrom A, Henthorn RW, Buckingham TA, Carlson MD, Carson PE.
    Circulation; 1994 Dec 06; 90(6):2843-52. PubMed ID: 7994829
    [Abstract] [Full Text] [Related]

  • 3. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
    Cardiac Arrhythmia Suppression Trial (CAST) Investigators.
    N Engl J Med; 1989 Aug 10; 321(6):406-12. PubMed ID: 2473403
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Crime, misdemeanor, and arrhythmia decoding CAST.
    Kerin NZ.
    J Clin Pharmacol; 1991 Nov 10; 31(11):1044-52. PubMed ID: 1753008
    [No Abstract] [Full Text] [Related]

  • 6. Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy.
    Bigger JT, Rolnitzky LM, Steinman RC, Fleiss JL.
    J Am Coll Cardiol; 1994 Mar 01; 23(3):733-40. PubMed ID: 7509355
    [Abstract] [Full Text] [Related]

  • 7. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) InvestigatorsThe CAPS Coordinating Center, University of Washington, JD-22, 1107 Northeast 45th, Room 505, Seattle, Washington 98105, USA..
    Am J Cardiol; 1988 Mar 01; 61(8):501-9. PubMed ID: 2894169
    [Abstract] [Full Text] [Related]

  • 8. Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
    Akiyama T, Pawitan Y, Campbell WB, Papa L, Barker AH, Rubbert P, Friedman L, Keller M, Josephson RA.
    J Am Geriatr Soc; 1992 Jul 01; 40(7):666-72. PubMed ID: 1607582
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled.
    Epstein AE, Bigger JT, Wyse DG, Romhilt DW, Reynolds-Haertle RA, Hallstrom AP.
    J Am Coll Cardiol; 1991 Jul 01; 18(1):14-9. PubMed ID: 1904891
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
    Kellen JC, Ettinger A, Todd L, Brezsnyak ML, Campion J, McBride R, Thomas S, Corum J, Schron E.
    Am J Crit Care; 1996 Jan 01; 5(1):19-25. PubMed ID: 8680488
    [Abstract] [Full Text] [Related]

  • 15. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
    Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL.
    N Engl J Med; 1991 Mar 21; 324(12):781-8. PubMed ID: 1900101
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.
    Akiyama T, Pawitan Y, Greenberg H, Kuo CS, Reynolds-Haertle RA.
    Am J Cardiol; 1991 Dec 15; 68(17):1551-5. PubMed ID: 1720917
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Akhtar M, Breithardt G, Camm AJ, Coumel P, Janse MJ, Lazzara R, Myerburg RJ, Schwartz PJ, Waldo AL, Wellens HJ.
    Circulation; 1990 Mar 15; 81(3):1123-7. PubMed ID: 1689621
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.